Skip to content

Candace Necyk

3 papers in the library · 30 citations · publishing 2018-2024

Papers

Sort Most recent Most cited

"This is you teaching you:" Exploring providers' perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapy.

PLoS One 2024 Elena Argento, Tashia Petker, Jayesh Vig et al. 3 citations

This study explores therapists' perspectives on experiential learning, competencies, and training in ketamine-assisted therapy (KAT), a form of psychedelic-assisted therapy (PAT). We aim to understand how therapists' personal psychedelic experiences influence their self-perceived competency and therapeutic relationships regarding KAT. Licensed therapists from Numinus Wellness clinics in Canada...

DOI: 10.1371/journal.pone.0306381 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Ketamine treatment Mental health professionals Experiential training +1

Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy

Frontiers in Neuroscience June 12, 2023 Elena Argento, Egiroh Omene, Alexandra Jaeger et al. 10 citations

Functional seizures, a primary subtype of functional neurological disorder (FND), are a known cause of serious neurological disability with an increasing awareness of their impact amongst the neuroscience community. Situated at the intersection of neurology and psychiatry, FND is characterized by a range of alterations in motor, sensory or cognitive performance, such as abnormal movements, limb...

A review of ketamine’s role in ECT and non-ECT settings

Neuropsychiatric Disease and Treatment June 1, 2018 Vytautas Jankauskas, Candace Necyk, James Chue et al. 17 citations

Up to 20% of depressed patients demonstrate treatment resistance to one or more adequate antidepressant trials, resulting in a disproportionately high burden of illness. Ketamine is a non-barbiturate, rapid-acting general anesthetic that has been increasingly studied in treatment resistant depression (TRD), typically at sub-anesthetic doses (0.5 mg/kg over 40 min by intravenous infusion). More...